03-BMT-148: A Phase I/II, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of IV Immunoglobulin G Containing High Anti-West Nile Virus Antibody Titers in Patients with, or at High-Risk

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology